NEWHALL CHARLES W III
SEC insider (Form 3/4/5 filer). CIK 0001005544. Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 16 reported Form 4/5 transactions since Sep 2024; latest on Feb 24, 2026. Located in ROCKVILLE, MD.
Companies NEWHALL CHARLES W III has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director
NEWHALL CHARLES W III
CIK: 0001005544
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
4.5K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect4.5K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
3K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
5K shares- - Nov 21, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect15K shares at avg. $12.98$195K - Oct 9, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect23.8K shares at avg. $50.73$1.2M - Oct 9, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $51.55$62K - Aug 27, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect3.6K shares at avg. $45.01$161K - Aug 25, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect1K shares at avg. $45.00$45K - Aug 22, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect1.4K shares at avg. $45.00$64K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 4,475 | - | - | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 4,475 | - | $0 | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 2,989 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Nov 21, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 15,000 | $12.98 | $194,700 | Direct |
| Oct 9, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 23,800 | $50.73 | $1,207,374 | Direct |
| Oct 9, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,200 | $51.55 | $61,860 | Direct |
| Aug 27, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 3,588 | $45.01 | $161,496 | Direct |
| Aug 25, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,000 | $45.00 | $45,000 | Direct |
| Aug 22, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,412 | $45.00 | $63,540 | Direct |
1-10 of 16 transactions